智通财经APP获悉，微创心通-B(02160)涨超13%，截至发稿，涨13.33%，报1.19港元，成交额183.14万港元。
消息面上，7月25日，微创心通宣布，近日，公司研发的AnchorMan®/锚王™左心耳封堵器及其导引系统，在澳大利亚获批上市；同时，公司新一代蓝牙远程监护系统SmartView Connect™ V15108在欧洲与澳大利亚获批上市。随着此次成功登陆澳大利亚市场，微创®心通的左心耳封堵器已覆盖中国（含港澳）、欧洲、拉美及澳洲。
公司指出，欧洲与澳大利亚是全球重要医疗市场，准入门槛高、监管要求严。此次获批，标志着全球高端市场对微创®心通方案的进一步认可。随着多款核心产品在国际主流市场持续落地，微创®心通在结构性心脏病及心律管理领域的全球化布局正加速推进。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.